Crossmark

Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine

Crossref DOI link: https://doi.org/10.1186/s40164-018-0122-9

Published Online: 2018-12-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Hanxiao

Jiao, Ying

Qin, Shuang

Zhao, Weiheng

Chu, Qian

Wu, Kongming
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81572608)

National Natural Science Foundation of China (81874120)

National Natural Science Foundation of China (81672984)

Wuhan Municipal Science and Technology Bureau (2017060201010170)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 21 October 2018

Accepted: 29 November 2018

First Online: 5 December 2018